Negative misconceptions surrounding opioid use disorders (OUD) and the FDA-approved medications for addiction treatment (MAT) can result in a disincentive for people to seek treatment. This web training will feature Dr. Thomas E. Freese, Co-Director and Director of Training of UCLA ISAP and Director of the PSATTC, and Albert Titman, an addiction counselor with extensive experience working in tribal communities. The web training will address some of the myths and misconceptions about OUD and MAT that feed into stigmatizing beliefs. Strategies for moving the field toward the use of less stigmatizing language when addressing substance use disorders will be discussed. The presenters will also review the importance of understanding personal biases and the impact these biases can have on patients and their ability to access available services. They will also address the connection between stigma and health disparities, particularly in marginalized populations, including American Indian/Alaska Native communities. Lastly, a peer advocate in long-term recovery will provide a patient’s perspective of how stigma can negatively affect the treatment and recovery experience. 
At the end of the web training, participants will be able to: 

1.    List three (3) negative ways stigma impacts people with substance use disorders.
2.    Provide three (3) examples of stigmatizing language and three (3) examples of alternative affirming language.
3.    List two (2) common misconceptions about MAT and the corresponding factual information.
4.    Discuss two (2) ways in which stigma and health disparities are connected, particularly in marginalized populations.